These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21341458)

  • 41. [Endothelial dysfunction and target organ damage in hypertensive patients complicating with or without metabolic syndrome].
    Lin JX; Yang X; Zheng XY; Chen DG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):710-4. PubMed ID: 17963628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular hemostasis in flowing blood in children.
    Van Cott EM; Grabowski EF
    Semin Thromb Hemost; 1998; 24(6):583-90. PubMed ID: 10066154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemostatic system in early respiratory distress syndrome: reduced fibrinolytic state?
    Yurdakök M; Yiğit S
    Turk J Pediatr; 1999; 41(4):489-93. PubMed ID: 10770117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interaction of blood and the vascular wall: hemostatic aspects].
    Gerlach E; Becker BF
    Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
    Małyszko J; Małyszko JS; Myśliwiec M
    Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The pathogenesis of erectile dysfunction in metabolic syndrome].
    Mazo EB; Gamidov SI; Iremashvili VV; Gasanov RV
    Vestn Ross Akad Med Nauk; 2008; (2):21-6. PubMed ID: 18368766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hemorheologic factors in hypertensive and diabetic retinopathy].
    Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B
    Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
    Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study.
    Wild SH; Byrne CD; Tzoulaki I; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Atherosclerosis; 2009 Apr; 203(2):604-9. PubMed ID: 18804759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between metabolic syndrome and vascular endothelium dysfunction in children and adolescents.
    Wei Y; Liu GL; Yang JY; Zheng RX; Jiang LH; Li YP; Gao FF
    Genet Mol Res; 2014 Oct; 13(4):8671-8. PubMed ID: 25366757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.
    Arteaga RB; Chirinos JA; Soriano AO; Jy W; Horstman L; Jimenez JJ; Mendez A; Ferreira A; de Marchena E; Ahn YS
    Am J Cardiol; 2006 Jul; 98(1):70-4. PubMed ID: 16784924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular biology of occlusive stroke in childhood.
    Shuman RM
    Neurol Clin; 1990 Aug; 8(3):553-70. PubMed ID: 2215456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates.
    Escolar G; Mazzara R; White JG; Castillo R; Ordinas A
    Blood Cells; 1992; 18(3):403-15; discussion 416-20. PubMed ID: 1286195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic syndrome and impaired vasomotor reactivity: causal relationship or chance association?
    Tsivgoulis G; Heliopoulos I
    Eur J Neurol; 2010 Dec; 17(12):e108; author reply e109. PubMed ID: 20722708
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prothrombotic state in patients with metabolic syndrome: an association with inflammation].
    Kaliuzhin VV; Sibireva OF; Bespalova ID; Kaliuzhina EV; Tkalich LM; Milovanova TA; Osikhov IA; Murashev BIu
    Ter Arkh; 2013; 85(10):29-33. PubMed ID: 24437215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
    Mezzano D; Pais EO; Aranda E; Panes O; Downey P; Ortiz M; Tagle R; González F; Quiroga T; Caceres MS; Leighton F; Pereira J
    Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlations between endothelial function in the systemic and cerebral circulation and insulin resistance in type 2 diabetes mellitus.
    Prakash K; Chandran DS; Khadgawat R; Jaryal AK; Deepak KK
    Diab Vasc Dis Res; 2016 Jan; 13(1):49-55. PubMed ID: 26408643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemostatic and rheological variables and risk of cardiovascular disease.
    Lowe GD; Rumley A; Whincup PH; Danesh J
    Semin Vasc Med; 2002 Nov; 2(4):429-39. PubMed ID: 16222632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.
    Picchi A; Gao X; Belmadani S; Potter BJ; Focardi M; Chilian WM; Zhang C
    Circ Res; 2006 Jul; 99(1):69-77. PubMed ID: 16741160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.